{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:37:27Z","timestamp":1754195847964,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771740"],"award-info":[{"award-number":["81771740"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"crossref","award":["7184251"],"award-info":[{"award-number":["7184251"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s10067-019-04807-8","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T02:03:07Z","timestamp":1573437787000},"page":"381-389","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The impact of different criteria sets on early remission and identifying its predictors in rheumatoid arthritis: results from an observational cohort (2009\u20132018)"],"prefix":"10.1007","volume":"39","author":[{"given":"Wenhui","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7219-9141","authenticated-orcid":false,"given":"Zhuoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,11]]},"reference":[{"key":"4807_CR1","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","volume":"389","author":"GR Burmester","year":"2017","unstructured":"Burmester GR, Pope JE (2017) Novel treatment strategies in rheumatoid arthritis. Lancet 389:2338\u20132348","journal-title":"Lancet"},{"key":"4807_CR2","first-page":"621","volume":"31","author":"VP Bykerk","year":"2013","unstructured":"Bykerk VP, Keystone EC, Kuriya B, Larch\u00e9 M, Thorne JC, Haraoui B (2013) Achieving remission in clinical practice: lessons from clinical trial data. Clin Exp Rheumatol 31:621\u2013632","journal-title":"Clin Exp Rheumatol"},{"key":"4807_CR3","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1136\/annrheumdis-2011-200274","volume":"71","author":"LG Schipper","year":"2012","unstructured":"Schipper LG, Vermeer M, Kuper HH, Hoekstra MO, Haagsma CJ, Den Broeder AA et al (2012) A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry. Ann Rheum Dis 71:845\u2013850","journal-title":"Ann Rheum Dis"},{"key":"4807_CR4","first-page":"820","volume":"36","author":"W Xie","year":"2018","unstructured":"Xie W, Li J, Zhang X, Li G, Hao Y, Zhao J, Wang L, Sun X, Fan Y, Zhang Z (2018) Trends in the activity of rheumatoid arthritis as the consequence of treat-to-target strategy: eight-year data from 2009 to 2016. Clin Exp Rheumatol 36:820\u2013828","journal-title":"Clin Exp Rheumatol"},{"key":"4807_CR5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.semarthrit.2010.10.004","volume":"40","author":"B Haraoui","year":"2011","unstructured":"Haraoui B, Pope J (2011) Treatment of early rheumatoid arthritis: concepts in management. Semin Arthritis Rheum 40:371\u2013388","journal-title":"Semin Arthritis Rheum"},{"key":"4807_CR6","first-page":"1099","volume":"77","author":"S Hilliquin","year":"2018","unstructured":"Hilliquin S, Hugues B, Mitrovic S, Gossec L, Fautrel B (2018) Ability of disease-modifying antirheumatic drugs to prevent or delay rheumatoid arthritis onset: a systematic literature review and meta-analysis. Ann Rheum Dis 77:1099\u20131106","journal-title":"Ann Rheum Dis"},{"key":"4807_CR7","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1136\/annrheumdis-2013-203339","volume":"73","author":"CA Scir\u00e8","year":"2014","unstructured":"Scir\u00e8 CA, Lunt M, Marshall T, Symmons DPM, Verstappen SMM (2014) Early remission is associated with improved survival in patients with inflammatory polyarthritis: results from the Norfolk Arthritis Register. Ann Rheum Dis 73:1677\u20131682","journal-title":"Ann Rheum Dis"},{"key":"4807_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1136\/annrheumdis-2017-211375","volume":"77","author":"G Akdemir","year":"2018","unstructured":"Akdemir G, Heimans L, Bergstra SA, Goekoop RJ, van Oosterhout M, van Groenendael JHLM, Peeters AJ, Steup-Beekman GM, Lard LR, de Sonnaville PBJ, Grillet BAM, Huizinga TWJ, Allaart CF (2018) Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study. Ann Rheum Dis 77:111\u2013118","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"4807_CR9","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1007\/s10067-019-04600-7","volume":"38","author":"Peter M. ten Klooster","year":"2019","unstructured":"Ten Klooster PM, Oude Voshaar MAH, Fakhouri W, de la Torre I, Nicolay C, van de Laar MAFJ (2019) Long-term clinical, functional, and cost outcomes for early rheumatoid arthritis patients who did or did not achieve early remission in a real-world treat-to-target strategy. Clin Rheumatol 38:2727\u20132736","journal-title":"Clinical Rheumatology"},{"key":"4807_CR10","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/acr.21649","volume":"64","author":"J Anderson","year":"2012","unstructured":"Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T et al (2012) Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res 64:640\u2013647","journal-title":"Arthritis Care Res"},{"key":"4807_CR11","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1002\/art.30494","volume":"63","author":"M Vermeer","year":"2011","unstructured":"Vermeer M, Kuper HH, Hoekstra M, Haagsma CJ, Posthumus MD, Brus HL, van Riel P, van de Laar M (2011) Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study. Arthritis Rheum 63:2865\u20132872","journal-title":"Arthritis Rheum"},{"key":"4807_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jbspin.2014.02.007","volume":"81","author":"I Hmamouchi","year":"2014","unstructured":"Hmamouchi I, Combe B, Fautrel B, Rincheval N, Lukas C (2014) Prevalence and concordance of early and sustained remission assessed by various validated indices in the early arthritis \u201cESPOIR\u201d cohort. Joint Bone Spine 81:409\u2013415","journal-title":"Joint Bone Spine"},{"key":"4807_CR13","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3899\/jrheum.141480","volume":"43","author":"T Rannio","year":"2016","unstructured":"Rannio T, Asikainen J, Kokko A, Hannonen P, Sokka T (2016) Early remission is a realistic target in a majority of patients with DMARD-naive rheumatoid arthritis. J Rheumatol 43:699\u2013706","journal-title":"J Rheumatol"},{"key":"4807_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/rheumatology\/key263","volume":"58","author":"JS Dekkers","year":"2019","unstructured":"Dekkers JS, Bergstra SA, Chopra A, Tikly M, Fonseca JE, Salomon-Escoto K, Huizinga TWJ, van der Woude D (2019) Autoantibody status is not associated with early treatment response to first-line methotrexate in patients with early rheumatoid arthritis. Rheumatology (Oxford) 58:149\u2013153","journal-title":"Rheumatology (Oxford)"},{"key":"4807_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"4807_CR16","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580\u20131588","journal-title":"Ann Rheum Dis"},{"key":"4807_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"2011","unstructured":"Landis JR, Koch GG (2011) The measurement of observer agreement for categorical data. Biometrics 33:159\u2013174","journal-title":"Biometrics"},{"key":"4807_CR18","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/ar3027","volume":"12","author":"LG Schipper","year":"2010","unstructured":"Schipper LG, Fransen J, den Broeder AA, Van Riel PL (2010) Time to achieve remission determines time to be in remission. Arthritis Res Ther 12:R97","journal-title":"Arthritis Res Ther"},{"key":"4807_CR19","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.3899\/jrheum.140137","volume":"41","author":"B Kuriya","year":"2014","unstructured":"Kuriya B, Xiong J, Boire G, Haraoui B, Hitchon C, Pope J, Thorne JC, Tin D, Keystone EC, Bykerk V, CATCH Investigators (2014) Earlier time to remission predicts sustained clinical remission in early rheumatoid arthritis--results from the Canadian Early Arthritis Cohort (CATCH). J Rheumatol 41:2161\u20132166","journal-title":"J Rheumatol"},{"key":"4807_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/rheumatology\/key054","volume":"58","author":"JT Einarsson","year":"2018","unstructured":"Einarsson JT, Willim M, Ernestam S, Saxne T, Geborek P, Kapetanovic MC (2018) Prevalence of sustained remission in rheumatoid arthritis: impact of criteria sets and disease duration, a Nationwide Study in Sweden. Rheumatology (Oxford) 58:227\u2013236","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"4807_CR21","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1111\/1756-185X.13651","volume":"22","author":"Wenhui Xie","year":"2019","unstructured":"Xie W, Li J, Zhang X, Sun X, Zhang Z (2019) Sustained clinical remission of rheumatoid arthritis and its predictive factors in an unselected adult Chinese population from 2009 to 2018. Int J Rheum Dis 22:1670\u20131678","journal-title":"International Journal of Rheumatic Diseases"},{"key":"4807_CR22","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/annrheumdis-2014-206047","volume":"74","author":"JA van Nies","year":"2015","unstructured":"van Nies JA, Tsonaka R, Gaujoux-Viala C, Fautrel B, van der Helm-van Mil AH (2015) Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden early arthritis clinic and ESPOIR cohorts. Ann Rheum Dis 74:806\u2013812","journal-title":"Ann Rheum Dis"},{"key":"4807_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10067-014-2828-3","volume":"34","author":"GY Wang","year":"2015","unstructured":"Wang GY, Zhang SL, Wang XR, Feng M, Li C, An Y et al (2015) Remission of rheumatoid arthritis and potential determinants: a national multi-center cross-sectional survey. Clin Rheumatol 34:221\u2013230","journal-title":"Clin Rheumatol"},{"key":"4807_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/rheumatology\/key275","volume":"58","author":"L Schapink","year":"2019","unstructured":"Schapink L, van den Ende CHM, Gevers LAHA, van Ede AE, den Broeder AA (2019) The effects of methotrexate and hydroxychloroquine combination therapy vs methotrexate monotherapy in early rheumatoid arthritis patients. Rheumatology (Oxford) 58:131\u2013134","journal-title":"Rheumatology (Oxford)"},{"key":"4807_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1136\/ard.2006.056937","volume":"66","author":"K Forslind","year":"2007","unstructured":"Forslind K, Hafstr\u00f6m I, Ahlm\u00e9n M, Svensson B, BARFOT Study Group (2007) Sex: a major predictor of remission in early rheumatoid arthritis? Ann Rheum Dis 66:46\u201352","journal-title":"Ann Rheum Dis"},{"key":"4807_CR26","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/acr.23497","volume":"70","author":"AC Boer","year":"2018","unstructured":"Boer AC, Boonen A, van der Helm van Mil AHM (2018) Is anti-citrullinated protein antibody-positive rheumatoid arthritis still a more severe disease than anti-citrullinated protein antibody-negative rheumatoid arthritis? A Longitudinal Cohort Study in Rheumatoid Arthritis Patients Diagnosed From 2000 Onward. Arthritis Care Res 70:987\u2013996","journal-title":"Arthritis Care Res"},{"key":"4807_CR27","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1002\/acr.22055","volume":"65","author":"J Zhang","year":"2013","unstructured":"Zhang J, Xie F, Delzell E, Chen L, Kilgore ML, Yun H et al (2013) Trends in the use of biologic agents among rheumatoid arthritis patients enrolled in the US medicare program. Arthritis Care Res 65:1743\u20131751","journal-title":"Arthritis Care Res"},{"key":"4807_CR28","first-page":"836","volume":"36","author":"C Yu","year":"2018","unstructured":"Yu C, Li M, Duan X, Fang Y, Li Q, Wu R, Liu S, Wang Y, Wu Z, Shi X, Jiang Z, Wang Y, Hsieh ED, Jin S, Jiang N, Wang Q, Zhao Y, Tian X, Zeng X, and the co-authors of CREDIT (2018) Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis. Clin Exp Rheumatol 36:836\u2013840","journal-title":"Clin Exp Rheumatol"},{"key":"4807_CR29","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1002\/art.34498","volume":"64","author":"LW Moreland","year":"2012","unstructured":"Moreland LW, O\u2019Dell JR, Paulus HE, Curtis JR, Bathon JM, St Clair EW et al (2012) A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of early aggressive rheumatoid arthritis trial. Arthritis Rheum 64:2824\u20132835","journal-title":"Arthritis Rheum"},{"key":"4807_CR30","doi-asserted-by":"publisher","first-page":"406","DOI":"10.7326\/0003-4819-146-6-200703200-00005","volume":"146","author":"YP Goekoop-Ruiterman","year":"2007","unstructured":"Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Peeters AJ, de Jonge-Bok JM, Mall\u00e9e C, de Beus WM, de Sonnaville PB, Ewals JA, Breedveld FC, Dijkmans BA (2007) Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med 146:406\u2013415","journal-title":"Ann Intern Med"},{"key":"4807_CR31","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/S0140-6736(12)60027-0","volume":"379","author":"RF van Vollenhoven","year":"2012","unstructured":"van Vollenhoven RF, Geborek P, Forslind K, Albertsson K, Ernestam S, Petersson IF et al (2012) Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial. Lancet 379:1712\u20131720","journal-title":"Lancet"},{"key":"4807_CR32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/NEJMoa1303006","volume":"369","author":"JR O\u2019Dell","year":"2013","unstructured":"O\u2019Dell JR, Mikuls TR, Taylor TH, Ahluwalia V, Brophy M et al (2013) Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med 369:307\u2013318","journal-title":"N Engl J Med"},{"key":"4807_CR33","doi-asserted-by":"publisher","first-page":"h1046","DOI":"10.1136\/bmj.h1046","volume":"350","author":"DL Scott","year":"2015","unstructured":"Scott DL, Ibrahim F, Farewell V, O\u2019Keeffe AG, Walker D, Kelly C et al (2015) Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial. BMJ 350:h1046","journal-title":"BMJ"},{"key":"4807_CR34","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12891-017-1673-3","volume":"18","author":"H Wijesinghe","year":"2017","unstructured":"Wijesinghe H, Galappatthy P, de Silva R, Seneviratne SL, Saravanamuttu U, Udagama P et al (2017) Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial. BMC Musculoskelet Disord 18:310","journal-title":"BMC Musculoskelet Disord"},{"key":"4807_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.7326\/M16-0713","volume":"167","author":"N Bansback","year":"2017","unstructured":"Bansback N, Phibbs CS, Sun H, O\u2019Dell JR, Brophy M, Keystone EC et al (2017) Triple therapy versus biologic therapy for active rheumatoid arthritis: a cost-effectiveness analysis. Ann Intern Med 167:8\u201316","journal-title":"Ann Intern Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04807-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04807-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04807-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:59:19Z","timestamp":1604969959000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04807-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,11]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["4807"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04807-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2019,11,11]]},"assertion":[{"value":"12 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The manuscript must be read and approved by all of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors consent"}},{"value":"This study was approved by the Ethics Committee of Peking University First Hospital.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical committee approval"}}]}}